Raquel M. Bengio
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluation of leukemic stem cell (CD26 +) in chronic myeloid leukemia patients with different molecular responses and in treatment-free remission.
Journal: Clinical and experimental medicine
Published: January 16, 2025
Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia.
Journal: Leukemia research
Published: August 08, 2024
GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Journal: Cancer epidemiology
Published: April 08, 2016
TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Journal: Blood cells, molecules & diseases
Published: March 29, 2016
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
Journal: Cancer investigation
Published: August 20, 2015
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.
Journal: European journal of haematology
Published: April 22, 2014
CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease.
Journal: Leukemia & lymphoma
Published: November 12, 2013
Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Journal: Blood cells, molecules & diseases
Published: February 04, 2013
Last Updated: 09/26/2026